172 related articles for article (PubMed ID: 8792700)
21. Saliva Interleukin-6 in patients with inflammatory bowel disease.
Aleksandra Nielsen A; Nederby Nielsen J; Schmedes A; Brandslund I; Hey H
Scand J Gastroenterol; 2005 Dec; 40(12):1444-8. PubMed ID: 16316893
[TBL] [Abstract][Full Text] [Related]
22. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
23. Circulating L-selectin levels and endothelial CD34 expression in inflammatory bowel disease.
Seidelin JB; Vainer B; Horn T; Nielsen OH
Am J Gastroenterol; 1998 Oct; 93(10):1854-9. PubMed ID: 9772044
[TBL] [Abstract][Full Text] [Related]
24. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
[TBL] [Abstract][Full Text] [Related]
25. Immunological status of the stomach in inflammatory bowel disease--comparison between ulcerative colitis and Crohn's disease.
Ando T; Watanabe O; Nobata K; Ishiguro K; Maeda O; Ishikawa D; Hasegawa M; Kondo S; Kato T; Ohmiya N; Niwa Y; Goto H
Digestion; 2008; 77(3-4):145-9. PubMed ID: 18577851
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
[TBL] [Abstract][Full Text] [Related]
27. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP
Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
[TBL] [Abstract][Full Text] [Related]
29. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
Seitz M; Zwicker M; Wider B
J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
[TBL] [Abstract][Full Text] [Related]
30. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
31. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease.
Ludwiczek O; Kaser A; Novick D; Dinarello CA; Rubinstein M; Tilg H
Eur Cytokine Netw; 2005; 16(1):27-33. PubMed ID: 15809203
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
[TBL] [Abstract][Full Text] [Related]
33. IL-33 is upregulated in colonocytes of ulcerative colitis.
Seidelin JB; Bjerrum JT; Coskun M; Widjaya B; Vainer B; Nielsen OH
Immunol Lett; 2010 Jan; 128(1):80-5. PubMed ID: 19913053
[TBL] [Abstract][Full Text] [Related]
34. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
35. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
36. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
[TBL] [Abstract][Full Text] [Related]
37. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
38. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
39. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
[TBL] [Abstract][Full Text] [Related]
40. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
